Keywords: icos, oral, impotence, drug, enters, ph, ii

ICOS' Oral Impotence Drug Enters Ph II

Article | 15 January 1998

Print This

US firm ICOS has started Phase II trials of IC351, an orally-active drugfor the treatment of male erectile dysfunction or ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in